Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | -61.75 | 34.95 | 121.13 | 89.07 |
Depreciation/ Depletion | 36.25 | 33.65 | 34.36 | 25.66 |
Non- Cash Items | 27.19 | 16.85 | 7.37 | 3.44 |
Changesin Working Capital | 8.53 | -10.80 | -139.25 | -126.36 |
Cashfrom Operating Activities | 10.22 | 74.66 | 23.60 | -8.20 |
Capital Expenditures | -135.50 | -117.26 | -103.98 | -102.53 |
Other Investing Cash Flow Items Total | 0.32 | 4.75 | 0.11 | 29.42 |
Cashfrom Investing Activities | -135.18 | -112.51 | -103.87 | -73.11 |
Financing Cash Flow Items | 26.80 | -20.07 | -8.91 | -4.75 |
Total Cash Dividends Paid | -2.94 | -2.94 | -2.94 | -2.94 |
Issuance( Retirement)of Stock Net | 0.08 | 0.13 | 0.30 | 0.67 |
Issuance( Retirement)of Debt Net | 101.02 | 60.65 | 92.03 | 88.35 |
Cashfrom Financing Activities | 124.96 | 37.77 | 80.48 | 81.34 |
Net Changein Cash | 0.00 | -0.08 | 0.22 | 0.03 |
Cash Interest Paid | 23.20 | 20.07 | 8.91 | 4.75 |
Cash Taxes Paid | 1.97 | 4.89 | 29.15 | 23.01 |
Astec Lifesciences Dividend Astec Lifesciences Bonus Astec Lifesciences News Astec Lifesciences AGM Astec Lifesciences Rights Astec Lifesciences Splits Astec Lifesciences Board Meetings Astec Lifesciences Key Metrics Astec Lifesciences Shareholdings Astec Lifesciences Profit Loss Astec Lifesciences Balance Sheet Astec Lifesciences Q1 Results Astec Lifesciences Q2 Results Astec Lifesciences Q3 Results Astec Lifesciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks